Patent application number | Description | Published |
20110165554 | METHODS AND BIOMARKERS FOR DIAGNOSING AND MONITORING PSYCHOTIC DISORDERS - A method of diagnosing or monitoring a psychotic disorder, or predisposition thereto, comprises measuring, in a sample taken from a subject, the levels of one or more peptide biomarkers listed herein. | 07-07-2011 |
20120071339 | BIOMARKERS - The invention relates to a method of diagnosing or monitoring multiple sclerosis. | 03-22-2012 |
20120071340 | BIOMARKERS - The invention relates to a method of diagnosing or monitoring major depressive disorder. | 03-22-2012 |
20120094858 | BIOMARKERS - The invention relates to a method of diagnosing or monitoring bipolar disorders, in particular bipolar I and bipolar II disorders, such as manic psychosis. | 04-19-2012 |
20130012402 | BIOMARKERS - The invention relates to a method of diagnosing or monitoring schizophrenia or other psychotic disorder. | 01-10-2013 |
20130017970 | BIOMARKERSAANM Bahn; SabineAACI CambridgeAACO GBAAGP Bahn; Sabine Cambridge GBAANM Levin; YishaiAACI CambridgeAACO GBAAGP Levin; Yishai Cambridge GBAANM Schwarz; EmanuelAACI CambridgeAACO GBAAGP Schwarz; Emanuel Cambridge GB - The invention relates to a method of diagnosing or monitoring schizophrenia or other psychotic disorder. | 01-17-2013 |
20130171166 | BIOMARKERS - The invention relates to a method of diagnosing or monitoring major depressive disorder using MMP-3 as a biomarker. | 07-04-2013 |
20130178385 | BIOMARKERS - The invention relates to a method of diagnosing or monitoring schizophrenia or other psychotic disorder. | 07-11-2013 |
20140200150 | BIOMARKERS - The invention relates to a method of differentially diagnosing schizophrenia, bipolar disorder and major depressive disorder. | 07-17-2014 |
20140200151 | BIOMARKERS - The invention relates to a method of differential diagnosis of schizophrenia or other psychotic disorder from a further psychiatric disorder. | 07-17-2014 |